Login / Signup

Abnormal oxidative metabolism in a quiet genomic background underlies clear cell papillary renal cell carcinoma.

Jianing XuEd ReznikHo-Joon LeeGunes GundemPhilip JonssonJudy SarungbamAnna BialikFrancisco Sanchez-VegaChad J CreightonJake HoekstraLi ZhangPeter SajjakulnukitDaniel KremerZachary TolstykaJozefina CasuscelliSteve StirdivantJie TangNikolaus SchultzPaul JengYiyu DongWenjing SuEmily H ChengPaul RussoJonathan A ColemanElli PapaemmanuilYing-Bei ChenVictor E ReuterChris SanderScott R KennedyJames J HsiehCostas A LyssiotisSatish K TickooAbraham Ari Hakimi
Published in: eLife (2019)
While genomic sequencing routinely identifies oncogenic alterations for the majority of cancers, many tumors harbor no discernable driver lesion. Here, we describe the exceptional molecular phenotype of a genomically quiet kidney tumor, clear cell papillary renal cell carcinoma (CCPAP). In spite of a largely wild-type nuclear genome, CCPAP tumors exhibit severe depletion of mitochondrial DNA (mtDNA) and RNA and high levels of oxidative stress, reflecting a shift away from respiratory metabolism. Moreover, CCPAP tumors exhibit a distinct metabolic phenotype uniquely characterized by accumulation of the sugar alcohol sorbitol. Immunohistochemical staining of primary CCPAP tumor specimens recapitulates both the depletion of mtDNA-encoded proteins and a lipid-depleted metabolic phenotype, suggesting that the cytoplasmic clarity in CCPAP is primarily related to the presence of glycogen. These results argue for non-genetic profiling as a tool for the study of cancers of unknown driver.
Keyphrases